What is the role of nurses in the Astana Declaration?
As part of strong multi-disciplinary health care teams, nurses and midwives make a significant contribution to delivering on the commitments made in the 2018 Astana Declaration on Primary Health Care, ensuring patient-centred care close to the community.
How many nurses will be needed by 2030?
For all countries to reach Sustainable Development Goal 3 on health and well-being, WHO estimates that the world will need an additional 9 million nurses and midwives by the year 2030. Nurses play a critical role in health promotion, disease prevention and delivering primary and community care.
What is the shortage of nurses and midwives?
Nurses and midwives account for nearly 50% of the global health workforce. There is a global shortage of health workers, in particular nurses and midwives, who represent more than 50% of the current shortage in health workers. The largest needs-based shortages of nurses and midwives are in South East Asia and Africa.
What percentage of the world's workforce is women?
Globally, 70% of the health and social workforce are women compared to 41% in all employment sectors. Nursing and midwifery occupations represent a significant share of the female workforce.
What is the WHO guidelines?
The guidelines are an innovation, matching scientific standards with the speed required to respond to an ongoing pandemic. Work on this began on 15 October when the WHO Solidarity Trial published its interim results.
What is conditional recommendation?
Updated 20 November 2020. * A conditional recommendation is issued when the evidence around the benefits and risks of an intervention are less certain. In this case, there is a conditional recommendation against the use of remdesivir. This means that there isn’t enough evidence to support its use.
Does Remdesivir improve survival?
WHO has issued a conditional recommendation against the use of remdesivir in hospitalized patients, regardless of disease severity, as there is currently no evidence that remdesivir improves survival and other outcomes in these patients. This recommendation, released on 20 November, is part of a living guideline on clinical care for COVID-19.